DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

43.23 -0.53 (-1.21%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SGEN $43.23 -1.21%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $43.85
Previous Close $43.76
Daily Range $42.80 - $44.39
52-Week Range $30.05 - $44.95
Market Cap $5.4B
P/E Ratio -66.30
Dividend (Yield) $0.00 (0.0%)
Volume 873,790
Average Daily Volume 1,201,275
Current FY EPS -$0.76




Drug Makers

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website:

News & Commentary Rss Feed

Is This Why the Street Keeps Doubting Gilead Sciences, Inc.?

Gilead Sciences looks like a screaming buy right now based on its fundamentals. But the Street apparently doesn't think so. Here's why.

Otonomy, Renren And Other Names To Watch Heading Into Next Week

Insiders keep on buying Macerich Co and Seattle Genetics

Trade-Ideas: Seattle Genetics (SGEN) Is Today's Post-Market Leader Stock

4 Momentem Stocks Breaking Out and Poised to Move Higher

First Week of July 17th Options Trading For Seattle Genetics (SGEN)

Insiders new buys : ZU, SGEN, MAC, SHLD, TBRA

Seattle Genetics (SGEN) in Focus: Stock Up 8.1% - Tale of the Tape

Seattle Genetics (SGEN) in Focus: Stock Up 8.1% - Tale of the Tape

Seattle Genetics (SGEN) Is Today's Perilous Reversal Stock

Insider Trading Alert - SGEN, NSP And TSCO Traded By Insiders

Insider Weekends - May 8, 2015

See More SGEN News...

SGEN's Top Competitors

SGEN $43.23 (-1.21%)
Current stock: SGEN
GILD $111.71 (0.44%)
Current stock: GILD
AMGN $163.59 (-0.15%)
Current stock: AMGN
BIIB $398.68 (-0.62%)
Current stock: BIIB